The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype
Open accessAbstract
Codeine is bioactivated to morphine, a strong opioid agonist, by the hepatic cytochrome P450 2D6 (CYP2D6); hence, the efficacy and safety of codeine as an analgesic are governed by CYP2D6 polymorphisms. Codeine has little therapeutic effect in patients who are CYP2D6 poor metabolizers, whereas the risk of morphine toxicity is higher in ultrarapid metabolizers. The purpose of this guideline (periodically updated at http://www.pharmgkb.org) is to provide information relating to the interpretation of CYP2D6 genotype test results to guide the dosing of codeine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype
Gaedigk, A., Simon, S., Pearce, R., Bradford, L., Kennedy, M., & Leeder, J. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100406 · Cited by 779
Self-citationCodeine Intoxication Associated with Ultrarapid CYP2D6 Metabolism
Gasche, Y., Daali, Y., Fathi, M., Chiappe, A., Cottini, S., Dayer, P., & Desmeules, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041888 · Cited by 702
Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother
Koren, G., Cairns, J., Chitayat, D., Gaedigk, A., & Leeder, S. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69255-6 · Cited by 684
Self-citationUniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs
Volpe, D. A., Tobin, G. A. M., Mellon, R. D., Katki, A. G., Parker, R. J., Colatsky, T., Kropp, T. J., & Verbois, S. L. (2011) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2010.12.007 · Cited by 446
Kirchheiner, J., Schmidt, H., Tzvetkov, M., Keulen, J.-T., Lötsch, J., Roots, I., & Brockmöller, J. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500406 · Cited by 439
LALOVIC, B., KHARASCH, E., HOFFER, C., RISLER, L., LIUCHEN, L., & SHEN, D. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.01.009 · Cited by 413
Self-citationThe hypoalgesic effect of tramadol in relation to CYP2D6*
Poulsen, L., Arendt-Nielsen, L., Brøsen, K., & Sindrup, S. H. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90211-8 · Cited by 386
Impact of CYP2D6 genotype on postoperative tramadol analgesia
Stamer, U. M., Lehnen, K., Höthker, F., Bayerer, B., Wolf, S., Hoeft, A., & Stuber, F. (2003) · Pain · doi:10.1016/s0304-3959(03)00212-4 · Cited by 333
Coffman, B. L., King, C. D., Rios, G. R., & Tephly, T. R. (1998) · PubMed · Cited by 322
Abram, S. E. (2007) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/s1073-5437(08)70202-x · Cited by 318
Madadi, P., Ross, C., Hayden, M., Carleton, B., Gaedigk, A., Leeder, J., & Koren, G. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.157 · Cited by 308
Self-citationEckhardt, K., Li, S., Ammon, S., Schänzle, G., Mikus, G., & Eichelbaum, M. (1998) · Pain · doi:10.1016/s0304-3959(98)00021-9 · Cited by 258
Court, M. H., Krishnaswamy, S., Hao, Q., Duan, S. X., Patten, C. J., von Moltke, L. L., & Greenblatt, D. J. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.9.1125 · Cited by 251
Concentrations of Tramadol and O-desmethyltramadol Enantiomers in Different CYP2D6 Genotypes
Stamer, U. M., Musshoff, F., Kobilay, M., Madea, B., Hoeft, A., & Stuber, F. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100152 · Cited by 241
Induction of CYP2D6 in pregnancy*
Wadelius, M., Darj, E., Frenne, G., & Rane, A. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90118-1 · Cited by 226
Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation
Heikkinen, T. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(02)17634-x · Cited by 209
Samer, C., Daali, Y., Wagner, M., Hopfgartner, G., Eap, C., Rebsamen, M., Rossier, M., Hochstrasser, D., Dayer, P., & Desmeules, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00709.x · Cited by 201
Gaedigk, A., Gotschall, R. R., Forbes, N. S., Simon, S. D., Kearns, G. L., & Leeder, J. S. (1999) · Pharmacogenetics and Genomics · doi:10.1097/01213011-199912000-00002 · Cited by 181
Self-citationMignat, C., Wille, U., & Ziegler, A. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00010-4 · Cited by 179
The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone
Samer, C., Daali, Y., Wagner, M., Hopfgartner, G., Eap, C., Rebsamen, M., Rossier, M., Hochstrasser, D., Dayer, P., & Desmeules, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00673.x · Cited by 166
Development and implementation of a pharmacist-managed clinical pharmacogenetics service
Crews, K. R., Cross, S. J., McCormick, J. N., Baker, D. K., Molinelli, A. R., Mullins, R., Relling, M. V., & Hoffman, J. M. (2011) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100113 · Cited by 158
Self-citationWillmann, S., Edginton, A. N., Coboeken, K., Ahr, G., & Lippert, J. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.151 · Cited by 142
Zackrisson, A.-L., Lindblom, B., & Ahlner, J. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.216 · Cited by 132
Lötsch, J., von Hentig, N., Freynhagen, R., Grießinger, N., Zimmermann, M., Doehring, A., Rohrbacher, M., Sittl, R., & Geißlinger, G. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32832b89da · Cited by 124
Pregnancy-induced increase in metoprolol metabolism
Högstedt, S., LINDBERG, B. S., Peng, D.-R., Regårdh, C. G., & Rane, A. (1985) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1985.114 · Cited by 124
Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy
Davis, M. P., Varga, J., Dickerson, D., Walsh, D., LeGrand, S. B., & Lagman, R. L. (2003) · Supportive Care in Cancer · doi:10.1007/s00520-002-0385-9 · Cited by 121
Andreassen, T. N., Eftedal, I., Klepstad, P., Davies, A. N., Bjordal, K., Lundström, S., Kaasa, S., & Dale, O. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1093-5 · Cited by 116
Pharmacogenetics of Analgesics: Toward the Individualization of Prescription
Rollason, V., Samer, C. F., Piguet, V., Dayer, P., & Desmeules, J. A. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.7.905 · Cited by 103
Kaplan, H. L., Busto, U. E., Baylon, G. J., Cheung, S. W., Otton, S. V., Somer, G. R., & Sellers, E. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36599-1 · Cited by 86
Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation?
Lötsch, J., Rohrbacher, M., Schmidt, H., Doehring, A., Brockmöller, J., & Geißlinger, G. (2009) · Pain · doi:10.1016/j.pain.2009.03.023 · Cited by 83
Guidelines for maternal codeine use during breastfeeding.
Madadi, P., Moretti, M. E., Djokanovic, N., et al. (2009) · PubMed · Cited by 61
Cited by
Hicks, J., Sangkuhl, K., Swen, J., Ellingrod, V., Müller, D., Shimoda, K., Bishop, Jr., Kharasch, E., Skaar, T., Gaedigk, A., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.597 · Cited by 685
Self-citationCrews, K. R., Gaedigk, A., Dunnenberger, H. M., Leeder, J. S., Klein, T. E., Caudle, K. E., Haidar, C. E., Shen, D. D., Callaghan, J. T., Sadhasivam, S., et al. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.254 · Cited by 680
Self-citationImplementing genomic medicine in the clinic: the future is here
Manolio, T. A., Chisholm, R. L., Ozenberger, B., Roden, D. M., Williams, M. S., Wilson, R., Bick, D., Bottinger, E. P., Brilliant, M. H., Eng, C., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2012.157 · Cited by 566
Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
Dunnenberger, H. M., Crews, K. R., Hoffman, J. M., Caudle, K. E., Broeckel, U., Howard, S. C., Hunkler, R. J., Klein, T. E., Evans, W. E., & Relling, M. V. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124835 · Cited by 511
Self-citationPrediction of CYP2D6 phenotype from genotype across world populations
Gaedigk, A., Sangkuhl, K., Whirl-Carrillo, M., Klein, T., & Leeder, J. S. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.80 · Cited by 506
Self-citation
Metadata
- Authors
- Crews, K. R., Gaedigk, A., Dunnenberger, H. M., Klein, T. E., Shen, D. D., Callaghan, J. T., Kharasch, E. D., & Skaar, T. C.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2011-12-28
- Volume
- 91
- Issue
- 2
- Pages
- 321-326
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W1993617813
- Cited by
- 371
- References
- 31
- FWCI
- 37.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.